Toxin-Specific Antibodies for the Treatment of Clostridium Difficile: Current Status and Future Perspectives

Toxins - Switzerland
doi 10.3390/toxins2050998
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Current Status of Clostridium Difficile Infection

Nippon Daicho Komonbyo Gakkai Zasshi
2018English

Toxin Neutralization as Therapy Strategy for Clostridium Difficile

Microbe
Microbiology
2016English

Nucleotide Sequence of Clostridium Difficile Toxin A

Nucleic Acids Research
Genetics
1990English

Preparation and Preliminary Application of Monoclonal Antibodies to the Receptor Binding Region of Clostridium Difficile Toxin B

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2015English

Congenital Hyperinsulinism: Current Status and Future Perspectives

Annals of Pediatric Endocrinology and Metabolism
Child HealthEndocrinologyPerinatologyPediatricsMetabolismDiabetes
2014English

Energy Medicine: Current Status and Future Perspectives

Global Advances In Health and Medicine
Medicine
2019English

Biomarkers of Parkinson's Disease: Current Status and Future Perspectives

Drug Discovery Today
Drug DiscoveryPharmacology
2013English

Utility of Clostridium Difficile Toxin B for Inducing Anti-Tumor Immunity

PLoS ONE
Multidisciplinary
2014English

Translational Research in Colorectal Cancer: Current Status and Future Perspectives of Multimodal Treatment Approach

Gastroenterology Research and Practice
HepatologyGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy